Dean Investment Associates’s Viavi Solutions VIAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
4,737
-168,256
-97% -$8.06M 0.03% 193
2026
Q1
$5.76M Sell
172,993
-152,551
-47% -$4.03M 0.81% 29
2025
Q4
$5.8M Buy
325,544
+82,281
+34% +$1.33M 0.83% 25
2025
Q3
$3.09M Buy
243,263
+41,841
+21% +$460K 0.43% 120
2025
Q2
$2.03M Sell
201,422
-13,694
-6% -$132K 0.3% 148
2025
Q1
$2.41M Sell
215,116
-113,457
-35% -$1.26M 0.36% 141
2024
Q4
$3.32M Buy
328,573
+48,334
+17% +$477K 0.47% 84
2024
Q3
$2.53M Buy
280,239
+183,481
+190% +$1.46M 0.34% 149
2024
Q2
$665K Sell
96,758
-108,978
-53% -$848K 0.09% 199
2024
Q1
$1.87M Buy
205,736
+30,647
+18% +$301K 0.26% 160
2023
Q4
$1.76M Buy
175,089
+28,432
+19% +$239K 0.25% 162
2023
Q3
$1.34M Sell
146,657
-60,759
-29% -$633K 0.22% 173
2023
Q2
$2.35M Sell
207,416
-133,595
-39% -$1.31M 0.38% 97
2023
Q1
$3.69M Buy
+341,011
New +$3.72M 0.59% 64

Other funds holding VIAV

Dean Investment Associates's VIAV Position: Q2 2026 in Review

Dean Investment Associates reduced its Viavi Solutions (VIAV) stake by 97% in Q2 2026, selling an estimated $8.06M and leaving 4,737 shares worth $226K. The position accounts for 0.03% of the portfolio, ranked #193.

Dean Investment Associates first reported a position in VIAV in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.8M in Q4 2025. 563 funds tracked by Wall St. Rank hold VIAV as of Q2 2026.

  • Dean Investment Associates held 4,737 shares of Viavi Solutions worth $226K as of Q2 2026.
  • Dean Investment Associates sold 168,256 Viavi Solutions shares in Q2 2026, an estimated $8.06M.
  • Viavi Solutions made up 0.03% of Dean Investment Associates's portfolio in Q2 2026, its #193 holding.
  • Dean Investment Associates first reported a position in Viavi Solutions in Q1 2023 and has held it in 14 quarters since.
  • Dean Investment Associates's Viavi Solutions position peaked at $5.8M in Q4 2025.
  • 563 funds tracked by Wall St. Rank held Viavi Solutions as of Q2 2026.

Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.